atenolol + metoprolol

Atenolol + metoprolol is a combination of two cardioselective beta-1 adrenergic receptor antagonists (beta blockers), each commonly used to manage cardiovascular conditions such as hypertension, angina pectoris, and certain arrhythmias. Both drugs work by blocking beta-1 adrenergic receptors in the heart, leading to decreased heart rate, reduced cardiac output, and lower blood pressure. Atenolol is hydrophilic and typically dosed once daily; metoprolol is more lipophilic and available in both immediate-release (metoprolol tartrate) and extended-release (metoprolol succinate) formulations[4][5][6]. While both are effective for lowering blood pressure and managing angina, clinical studies suggest that metoprolol may provide greater reduction in cardiovascular mortality compared to atenolol[5]. The combination of these two agents is not standard clinical practice due to overlapping mechanisms of action; they are usually prescribed separately rather than together.

Other names

Atenolol/Metoprolol tartrate